|Novozymes AS -- USA Stock|| |
USD 52.55 0.000001 0.00%
Executive VP of Food and Beverages
Mr. Andrew Fordyce was Executive Vice President, Food Beverages at Novozymes AS since February 8, 2016. Previously, he was Executive Vice President of Business Operations at the Company from April 1, 2013 until February 8, 2016. He was previously Vice President of Sales and Customer Solutions. Since joining the Company in 1993, he has held several positions in commercial operations, research and development and production in Denmark, Switzerland and the United States. He holds Doctorate of Philosophy degree in Chemical Engineering from the University of Texas at Austin.
Age: 54 EVP Since 2016 Ph.D
45 44 46 00 00 http://www.novozymes.com
The company has return on total asset (ROA)
of 13.68 %
which means that it generated profit of $13.68 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE)
of 27.12 %
meaning that it generated $27.12 on every $100 dollars invested by stockholders.
The company has accumulated 375.71 M in total debt with debt to equity ratio (D/E) of 20.1 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Novozymes AS has Current Ratio of 1.31 which is within standard range for the sector.
|Found 1 records|
|Richard Egosi||Teva Pharmaceutical Industries |
Novozymes AS produces and sells industrial enzymes and microorganisms worldwide. Novozymes AS was founded in 1925 and is headquartered in Bagsvaerd, Denmark. Novozymes AS is traded on OTC Market in USA.Novozymes AS (NVZMF) is traded on OTC Market in USA. It is located in Krogshoejvej 36 and employs 5,973 people.